Conditional RNAi: Towards a silent gene therapy
- Authors
- Lee, Sang-Kyung; Kumar, Priti
- Issue Date
- Jul-2009
- Publisher
- ELSEVIER
- Keywords
- Conditional RNAi; Inducible RNAi; Transgenic RNAi; Cre/loxP; Tetracycline inducible system
- Citation
- ADVANCED DRUG DELIVERY REVIEWS, v.61, no.7-8, pp.650 - 664
- Indexed
- SCIE
SCOPUS
- Journal Title
- ADVANCED DRUG DELIVERY REVIEWS
- Volume
- 61
- Number
- 7-8
- Start Page
- 650
- End Page
- 664
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/176578
- DOI
- 10.1016/j.addr.2009.03.016
- ISSN
- 0169-409X
- Abstract
- RNA interference (RNAi) has the potential to permit the downregulation of virtually any gene. While transgenic RNAi enables stable propagation of the resulting phenotype to progeny, the dominant nature of RNAi limits its use to applications where the continued suppression of gene expression does not disturb normal cell functioning. This is of particular importance when the target gene product is essential for cell survival, development or differentiation. It is therefore desirable that knockdown be externally regulatable. This review is aimed at providing an overview of the approaches for conditional RNAi in mammalian systems, with a special mention of studies employing these approaches to target therapeutically/biologically relevant molecules, their advantages and disadvantages, and a pointer towards approaches best suited for RNAi-based gene therapy.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 공과대학 > 서울 생명공학과 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/176578)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.